Buyer profile
NHS England
Get alerts when NHS England publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
1,930
Known spend
£211bn
1801 disclosed
Average value
£117m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
University College London Hospitals NHS Foundation Trust
19 winslatest 22 Sept 2026£5bn
- 2
ACCORD-UK LTD
£2bn
- 3
Zentiva Pharma UK Ltd
17 winslatest 27 Aug 2026£2bn
- 4
Teva UK Limited
15 winslatest 27 Aug 2026£2bn
- 5
Pfizer Ltd
14 winslatest 27 Aug 2026£3bn
- 6
Imperial College Healthcare NHS Trust
13 winslatest 28 Jan 2026£5bn
- 7
Guy's and St Thomas' NHS Foundation Trust
12 winslatest 22 Sept 2026£11bn
- 8
DR REDDY'S LABORATORIES (UK) LIMITED
£1bn
- 9
Cambridge University Hospitals NHS Foundation Trust
11 winslatest 18 May 2026£5bn
- 10
Sheffield Teaching Hospitals NHS Foundation Trust
11 winslatest 22 Sept 2026£775m
What they buy
By CPV categoryHealth & social workCPV 85
320 contracts · £42bn
Medical equipment & pharmaCPV 33
163 contracts · £25bn
Business servicesCPV 79
92 contracts · £270m
IT servicesCPV 72
58 contracts · £521m
Education & trainingCPV 80
41 contracts · £42m
SoftwareCPV 48
24 contracts · £1bn
R&D servicesCPV 73
21 contracts · £9m
Architectural & engineeringCPV 71
10 contracts · £334m
Renewal radar
Awarded contracts predicted to come up for re-tender in the next 18 months
- HSCN-AWS Connectivity Service for Spine
Predicted using median duration of UK contracts in the same CPV division (11 months from contract start date → renewal expected by May 2027).
May 2027
40% confident
- LeDeR Web Platform
Predicted using median duration of past contracts from this buyer in the same CPV division (11 months from contract start date → renewal expected by Jul 2027).
Jul 2027
60% confident
- Cyber School - Off The Shelf
Predicted using median duration of UK contracts in the same CPV division (15 months from contract start date → renewal expected by Nov 2027).
Nov 2027
40% confident
Tender activity
Notices published per month — last 24 months
All contracts (1930)
Clinical evidence reviews
The notice relates to the award of a call-off contract for clinical evidence reviewed, awarded following a further-competition via the Health Systems Support Framework Agreement. N
NHS national framework agreement for the supply of products for the treatment of haemophilia A
NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social C
Award - NHS england (london region) - ETTF professional support 2020 - 2021
Award for construction consultancy services. The supplier will provide specialist resources to support in the review, management and delivery of the Estates Transformation and Tech
Market engagement - improving access to psychological therapies (IAPT) for deaf adults
NHS England is looking to commission a service to deliver IAPT compliant services to Deaf adults through British Sign Language. NHS England is asking potential bidders to complete
Coproducing personalised care grant
NHS England is looking to compete a Grant to support a current programme of work that enables people with lived experience to play a full part in strategic co-production at a natio
NHS national framework agreement for adalimumab injection
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the
NHS national branded proprietary products (interim agreement) - contracts finder award
NHS Framework Agreement for Branded Medicines - National Interim Offer reference number: CM/PHR/19/5584 Period of framework agreement: 1st May 2020 to 30th April 2021 with an optio
Specialised - products for the treatment of haemophilia A
Products for the treatment of Haemophilia A
NHS national pharmaceuticals transition 2020_1
NHS National Pharmaceuticals Transition 2020_1 Offer reference number: CM/PHG/19/5586 Period of framework agreement: The total maximum duration of the framework agreement to be no
Low calorie diets programme
The NHS Diabetes Programme, a joint partnership between NHS England and NHS Improvement, Public Health England and Diabetes UK, wish to procure a maximum of 10 providers to pilot a
Primary care testbeds - support partner
The Primary Care Testbeds programme is a structured approach to developing and testing of any potential changes to the General Medical Services contract, to gather evidence about h
Rapid diagnostic centres - evaluation partner
The Rapid Diagnostic Centres (RDCs) programme is a new programme of work in England which will contribute to the ambition of the NHS Long Term Plan to improve earlier and faster di
Quality of life cancer surveys
The purpose of the procurement is to select the best value, appropriately skilled and experienced supplier to collect survey data from cancer patients using both digital and paper
Specialised - human cell line recombinant factor VIII
Human Cell Line Recombinant Factor VIII
Specialised - recombinant factor VIII
Recombinant Factor VIII
NHS national framework agreement home delivery service pulmonary hypertension
NHS National Framework Agreement Home Delivery Service Pulmonary Hypertension Offer reference number: CM/MSR/17/5539 Period of framework agreement: 1 June 2020 to 31 May 2022 with
Future service programme supplier engagement event
This is a notice to invite interested Suppliers to attend a Supplier Engagement Day where we will provide information on our IT transformation programme as well as the future oppor
NHS framework agreement - north of england - tranche B
NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Fondaparinux Offer reference number: CM/P
Personalised care institute convenor
This is an opportunity to tender for the Personalised Care Institute Convenor Contract, interested suppliers should review the specification and other ITT documents via the Bravo S
NHS national framework agreement for the supply of lanadelumab
NHS National Framework Agreement for the supply of Lanadelumab. The framework agreement will commence on 1.1.2020 for a period of 12 months, with options to extend for a further 36